Multiple Sclerosis
Multiple sclerosis (MS) is a chronic autoimmune, inflammatory disease of the central nervous system (CNS), which causes damage to myelin and axons, resulting in neurological symptoms such as partial loss of sight, paresthesias and ataxia.
Multiple Sclerosis Products Targets
- STAT (10)
- Voltage-gated Potassium (KV) Channel (38)
- Integrin Receptor (15)
- Others (29)
- Complement (2)
- Vitamin D Receptor (10)
- PORCN (4)
- beta-catenin (13)
- Casein Kinase 1 (7)
- AMPA Receptor (45)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- NMDA Receptor (87)
- Kainate Receptor (22)
- Chemokine CXC Receptor (9)
- Chemokine CC Receptor (13)
- TRPM (8)
- Tankyrase (5)
- ROS and Other Gaseous Donor (8)
- Nrf2 (5)
- ITK (2)
- ASK1 (2)
- Acid-Sensing Ion Channel (3)
- Calcium-Activated Potassium (KCa) Channel (19)
- Inward Rectifier Potassium (Kir) Channel (21)
- NCX (5)
- Retinoid X Receptor (13)
- Cytokine (15)
Products for Multiple Sclerosis - Page 23
- Cat.No. Product Name Information/Activity
-
BCC7401
Tocrifluor T1117
1186195-59-4
-
BCC5971
HU 308
Potent and selective CB<sub>2</sub> agonist
-
BCC5744
JWH 015
155471-08-2
-
BCC1353
AM630
6-Iodopravadoline (AM630) is a selective CB2 antagonist with Ki of 31.2 nM, and displays 165-fold selectivity over CB1 receptors.
-
BCC6282
COR 170
1048039-15-1
-
BCC7380
JTE 907
282089-49-0
-
BCC4410
BML-190
Potent, selective CB<sub>2</sub> ligand,BML-190 is a selective cannabinoid CB2 receptor inverse agonist with Ki of 435 nM, with 50-fold selectivity over CB1 receptor.
-
BCC7011
Abn-CBD
22972-55-0
-
BCC7487
O-1602
317321-41-8
-
BCC7084
Oleylethanolamide
Oleoylethanolamide is a high affinity endogenous PPAR-α agonist, which plays an important role in the treatment of obesity and arteriosclerosis.
